v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE

TITLE:

FREQUENCY OF CARCINOMA OF ENDOMETRIUM AND CERVIX IN THE FEMALES SUFFERING FROM POST MENOPAUSAL BLEEDING

AUTHORS:

Dr Naeem Akhtar Khokhar, Dr Shabnam Naz Shaikh, Dr Nusrat Aijaz, Dr Tahira Parveen Awan, Dr Farzana, Dr Tahira Parveen Mahar

ABSTRACT:

Objective: The objective of this study is to find out the rate of carcinoma of endometrium and cervix in women presenting with post-menopausal bleeding, diagnosed by histopathologic interpretation. Study Design: A descriptive, cross-sectional study. Place & Duration of Study: The duration of this study was from 16 June, 2014 to 15 Dec, 2014. This study conducted at department of Obstetrics and Gynaecology at Sheikh Zayed Women Hospital Larkana. Patients and Methods: All patients with age 45 years and above with any parity presented with post-menopausal blood stained vaginal discharge either bleeding were enrolled. A meticulous medical assessment carried out, that includes a history of anomaly oriented and clinical evaluation. The bleeding details like the mode of the start of post-menopausal bleeding, quantity & episodes number, post coital bleeding & any anomalous release noted down. The history of the personnel & family about the malignancies of the genital tract like Ca cervix and endometrium was focus of enquiry. Results: The average age of the patients was 62.610 ± 6.960 years. Mean parity of the patients was 3.48 ±2.11. Majority of the patients 105 (81%) were presented with ≤5 parity whereas 24 (19%) were presented with >5 parity. Endometrial carcinoma was available in 16% (n: 21) patients and cervical carcinoma was present in 14% (n: 18) patients. Conclusion: Histopathologic interpretation is the best marker for the identification of endometrium and cervix carcinoma in women having post-menopausal bleeding Keywords: Endometrium Carcinoma, Cervical Carcinoma, Post-Menopausal Bleeding, histopathologic interpretation.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.